REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer

This study has been terminated.
(Lack of efficacy)
Sponsor:
Information provided by (Responsible Party):
Professor David Cunningham, Royal Marsden NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT00824785
First received: January 16, 2009
Last updated: December 10, 2012
Last verified: December 2012